It was demonstrated that miR-342 inhibits the proliferation and migration of the triple negative breast cancer cell invasion by targeting cofilin-1 and promoting apoptosis which identifies miR-342 as a novel therapeutic target in breast cancer. The gene discussed is CFL1; the disease is triple-negative breast carcinoma.